Novak & Powell Financial Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$639K Buy
4,975
+15
+0.3% +$1.76K 0.3% 69
2026
Q1
$597K Buy
4,960
+86
+2% +$9.93K 0.32% 70
2025
Q4
$513K Sell
4,874
-61
-1% -$5.73K 0.27% 83
2025
Q3
$414K Buy
4,935
+21
+0.4% +$1.73K 0.22% 92
2025
Q2
$389K Buy
4,914
+19
+0.4% +$1.51K 0.27% 81
2025
Q1
$439K Buy
4,895
+421
+9% +$39.3K 0.27% 81
2024
Q4
$445K Buy
4,474
+15
+0.3% +$1.55K 0.27% 83
2024
Q3
$506K Buy
4,459
+12
+0.3% +$1.43K 0.29% 81
2024
Q2
$551K Buy
4,447
+11
+0.2% +$1.42K 0.34% 71
2024
Q1
$585K Buy
4,436
+13
+0.3% +$1.6K 0.44% 58
2023
Q4
$482K Buy
+4,423
New +$459K 0.32% 77

Other funds holding MRK

Novak & Powell Financial Services's MRK Position: Q2 2026 in Review

Novak & Powell Financial Services increased its Merck (MRK) stake by 0.3% in Q2 2026, buying an estimated $1.76K and bringing the position to 4,975 shares worth $639K. The position accounts for 0.3% of the portfolio, ranked #69.

Novak & Powell Financial Services first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Novak & Powell Financial Services held 4,975 shares of Merck worth $639K as of Q2 2026.
  • Novak & Powell Financial Services bought 15 Merck shares in Q2 2026, an estimated $1.76K.
  • Merck made up 0.3% of Novak & Powell Financial Services's portfolio in Q2 2026, its #69 holding.
  • Novak & Powell Financial Services first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Novak & Powell Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.